Sunshine Biopharma (SBFM) Strong Buy 💪

$Sunshine Biopharma Inc.(SBFM)$

Sunshine Biopharma (NASDAQ:SBFM) stock is falling on Monday after the pharmaceutical company received a delisting notice from the Nasdaq Exchange.

That delisting notice notes that shares of SBFM stock have been trading for less than the $1 minimum bid price for too long. The company was first notified of this back in March 2023. It used extensions to try and regain compliance during the last year.

However, shares of SBFM stock have continued to fall, resulting in it trading for less than 10 cents per share for 10 consecutive business days. This has triggered another delisting notice. The company has sought an appeal, and a meeting with the Nasdaq Hearings Panel is set for April 25, 2024.

What This Means for SBFM Stock

Sunshine Biopharma notes that it intends to undergo a 1-for-40 reverse stock split as a way to boost the price of its shares. It already has shareholder approval for this action and hopes doing so will get it back above the Nasdaq’s minimum listing requirement.

News of the delisting notice and reverse stock split plans has brought heavy trading to SBFM shares this morning. That has over 4 million units trading hands as of this writing. That’s above its daily average trading volume of about 2.3 million shares.

SBFM stock is down 17% as of Monday morning.

💰 Stocks to watch today?(26 Apr)

1. What news/movements are worth noting in the market today? Any stocks to watch? 2. What trading opportunities are there? Do you have any plans? 🎁 Make a post here, everyone stands a chance to win Tiger coins!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

9

2

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":281422517276768,"tweetId":"281422517276768","gmtCreate":1709735180763,"gmtModify":1709735190202,"author":{"id":4088639346266630,"authorId":4088639346266630,"authorIdStr":"4088639346266630","name":"daz888888888","avatar":"https://community-static.tradeup.com/news/8bbe8cd95504dc1e0dd3af78504d3f7e","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"93.76%","individualDisplayEnabled":0},"individualDisplayBadges":[],"starInvestorFlag":false},"themes":[{"themeId":"470d3ab575ca43caaed8156645b7ccbe","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"💰 Stocks to watch today?(26 Apr)","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":470d3ab575ca43caaed8156645b7ccbe}&rnconfig={\"headerBarHidden\": true}","description":"1. What news/movements are worth noting in the market today? Any stocks to watch? \n2. What trading opportunities are there? Do you have any plans?\n🎁 Make a post here, everyone stands a chance to win Tiger coins!","image":"https://static.tigerbbs.com/cd8eaff2e99964ab7a80d92cc196fcd3"}],"images":[{"img":"https://community-static.tradeup.com/news/d8340cb43da8b029b1df17fd230931c9","width":"594","height":"345"},{"img":"https://community-static.tradeup.com/news/485db889bf97d3d7cbf8b31720c58976","width":"4032","height":"3024"}],"coverImages":[{"img":"https://community-static.tradeup.com/news/485db889bf97d3d7cbf8b31720c58976","width":"4032","height":"3024"}],"title":"Sunshine Biopharma (SBFM) Strong Buy 💪 ","html":"<html><head></head><body><p><a href=\"https://ttm.financial/S/SBFM\">$Sunshine Biopharma Inc.(SBFM)$&nbsp;</a></p>\n<p>Sunshine Biopharma (NASDAQ:SBFM) stock is falling on Monday after the pharmaceutical company received a delisting notice from the Nasdaq Exchange.</p>\n<p>That delisting notice notes that shares of SBFM stock have been trading for less than the $1 minimum bid price for too long. The company was first notified of this back in March 2023. It used extensions to try and regain compliance during the last year.</p>\n<p>However, shares of SBFM stock have continued to fall, resulting in it trading for less than 10 cents per share for 10 consecutive business days. This has triggered another delisting notice. The company has sought an appeal, and a meeting with the Nasdaq Hearings Panel is set for April 25, 2024.</p>\n<p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/d8340cb43da8b029b1df17fd230931c9\" tg-width=\"594\" tg-height=\"345\"><span></span></p>\n<p>What This Means for SBFM Stock</p>\n<p>Sunshine Biopharma notes that it intends to undergo a 1-for-40 reverse stock split as a way to boost the price of its shares. It already has shareholder approval for this action and hopes doing so will get it back above the Nasdaq’s minimum listing requirement.</p>\n<p>News of the delisting notice and reverse stock split plans has brought heavy trading to SBFM shares this morning. That has over 4 million units trading hands as of this writing. That’s above its daily average trading volume of about 2.3 million shares.</p>\n<p>SBFM stock is down 17% as of Monday morning.</p>\n<p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/485db889bf97d3d7cbf8b31720c58976\" tg-width=\"4032\" tg-height=\"3024\"><span></span></p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://ttm.financial/S/SBFM\">$Sunshine Biopharma Inc.(SBFM)$&nbsp;</a></p>\n<p>Sunshine Biopharma (NASDAQ:SBFM) stock is falling on Monday after the pharmaceutical company received a delisting notice from the Nasdaq Exchange.</p>\n<p>That delisting notice notes that shares of SBFM stock have been trading for less than the $1 minimum bid price for too long. The company was first notified of this back in March 2023. It used extensions to try and regain compliance during the last year.</p>\n<p>However, shares of SBFM stock have continued to fall, resulting in it trading for less than 10 cents per share for 10 consecutive business days. This has triggered another delisting notice. The company has sought an appeal, and a meeting with the Nasdaq Hearings Panel is set for April 25, 2024.</p>\n<p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/d8340cb43da8b029b1df17fd230931c9\" tg-width=\"594\" tg-height=\"345\"><span></span></p>\n<p>What This Means for SBFM Stock</p>\n<p>Sunshine Biopharma notes that it intends to undergo a 1-for-40 reverse stock split as a way to boost the price of its shares. It already has shareholder approval for this action and hopes doing so will get it back above the Nasdaq’s minimum listing requirement.</p>\n<p>News of the delisting notice and reverse stock split plans has brought heavy trading to SBFM shares this morning. That has over 4 million units trading hands as of this writing. That’s above its daily average trading volume of about 2.3 million shares.</p>\n<p>SBFM stock is down 17% as of Monday morning.</p>\n<p class=\"t-img-caption\"><img src=\"https://community-static.tradeup.com/news/485db889bf97d3d7cbf8b31720c58976\" tg-width=\"4032\" tg-height=\"3024\"><span></span></p></body></html>","text":"$Sunshine Biopharma Inc.(SBFM)$ Sunshine Biopharma (NASDAQ:SBFM) stock is falling on Monday after the pharmaceutical company received a delisting notice from the Nasdaq Exchange. That delisting notice notes that shares of SBFM stock have been trading for less than the $1 minimum bid price for too long. The company was first notified of this back in March 2023. It used extensions to try and regain compliance during the last year. However, shares of SBFM stock have continued to fall, resulting in it trading for less than 10 cents per share for 10 consecutive business days. This has triggered another delisting notice. The company has sought an appeal, and a meeting with the Nasdaq Hearings Panel is set for April 25, 2024. What This Means for SBFM Stock Sunshine Biopharma notes that it intends to undergo a 1-for-40 reverse stock split as a way to boost the price of its shares. It already has shareholder approval for this action and hopes doing so will get it back above the Nasdaq’s minimum listing requirement. News of the delisting notice and reverse stock split plans has brought heavy trading to SBFM shares this morning. That has over 4 million units trading hands as of this writing. That’s above its daily average trading volume of about 2.3 million shares. SBFM stock is down 17% as of Monday morning.","highlighted":1,"essential":1,"paper":2,"likeSize":9,"commentSize":0,"repostSize":2,"favoriteSize":0,"link":"https://ttm.financial/post/281422517276768","repostId":0,"isVote":1,"tweetType":1,"viewCount":721,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["SBFM"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":1097,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/281422517276768"}